<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Thyroid function was evaluated in children surviving disease-free for 2 years or more following bone marrow transplantation (BMT) for severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (27 patients), <z:hpo ids='HP_0011009'>acute</z:hpo> non-lymphoblastic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (28 patients), and <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (25 patients) </plain></SENT>
<SENT sid="1" pm="."><plain>Pre-BMT conditioning consisted of high dose chemotherapy and total lymphoid irradiation with 750 cGy for patients with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, and for patients with <z:hpo ids='HP_0001909'>leukemia</z:hpo>, high dose chemotherapy and single dose total body irradiation with 750-850 cGy (33 patients) or fractionated total body irradiation with 1320 cGy (20 patients) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0008223'>Compensated hypothyroidism</z:hpo> (<z:hpo ids='HP_0002925'>elevated thyroid stimulating hormone</z:hpo> (TSH) with a <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="4" ids="30660">thyroxine</z:chebi> index) occurred in 20/80 patients with a median time of <z:hpo ids='HP_0003674'>onset</z:hpo> of 12.3 months post-BMT (range 4-30) </plain></SENT>
<SENT sid="3" pm="."><plain>No patients developed <z:hpo ids='HP_0000832'>primary hypothyroidism</z:hpo> (<z:hpo ids='HP_0002925'>elevated thyroid stimulating hormone</z:hpo> with low <z:chebi fb="4" ids="30660">thyroxine</z:chebi> index) </plain></SENT>
<SENT sid="4" pm="."><plain>In seven patients, <z:hpo ids='HP_0008223'>compensated hypothyroidism</z:hpo> was transient with TSH returning to <z:mpath ids='MPATH_458'>normal</z:mpath> at a median of 60 months post-BMT (range 11-75) </plain></SENT>
<SENT sid="5" pm="."><plain>Six patients with <z:hpo ids='HP_0008223'>compensated hypothyroidism</z:hpo> received thyroid hormone replacement therapy </plain></SENT>
<SENT sid="6" pm="."><plain>Time to development of <z:hpo ids='HP_0008223'>compensated hypothyroidism</z:hpo> was associated (p = 0.03) with underlying disease and radiation (11 of 27 patients with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> + total lymphoid irradiation versus nine of 53 patients with <z:hpo ids='HP_0001909'>leukemia</z:hpo> + total body irradiation) </plain></SENT>
<SENT sid="7" pm="."><plain>In <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> patients, but not patients with <z:hpo ids='HP_0001909'>leukemia</z:hpo>, the incidence of thyroid hypofunction 5 years post-transplant was significantly higher (p less than 0.001) in those receiving <z:chebi fb="0" ids="44185">methotrexate</z:chebi> alone (82%) as prophylaxis for <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> compared with those receiving a regimen of <z:chebi fb="0" ids="44185">methotrexate</z:chebi>, antithymocyte globulin and <z:chebi fb="0" ids="8382">prednisone</z:chebi> (16%) </plain></SENT>
</text></document>